BackHUTCHMED (China) Limited Overview
HUTCHMED (China) Limited - ADR

HUTCHMED (China) Limited P/E Ratio

HUTCHMED (China) Limited (HCM) has a P/E ratio of 4.58, below the Healthcare sector average of 26.36.

Get informed when a big investor buys or sells

+ Follow

P/E Ratio

4.58

P/E Ratio

4.58

The P/E ratio compares a company's stock price to its earnings per share. A lower P/E ratio may indicate that the stock is undervalued.

Average P/E Ratio (Comparison Companies)

Loading

P/E Ratio History

Loading

P/E Ratio Comparison

Loading

HUTCHMED (China) Limited (HCM) FAQ

HUTCHMED (China) Limited (HCM) currently reports a P/E ratio of 4.58. That is below the Healthcare sector average of 26.36. Use the charts on this page to explore HUTCHMED (China) Limited's P/E ratio history and peer comparisons.

HUTCHMED (China) Limited's P/E ratio of 4.58 is lower than the Healthcare sector average of 26.36. That is roughly 82.6% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

The P/E ratio is a valuation multiple that relates HUTCHMED (China) Limited's market price to a fundamental measure such as earnings, sales, or book value. At 4.58, HCM can look expensive or cheap only in context — versus its own history, growth rate, and Healthcare peers. Higher multiples often price in stronger expected growth; lower ones can signal value or concern.

Start with the current P/E ratio of 4.58, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 26.36. From there, open related valuation or income-statement pages for HUTCHMED (China) Limited, and consider following HCM for alerts when major investors trade the stock.

HUTCHMED (China) Limited is classified in the Healthcare sector. On P/E ratio, it currently shows 4.58 versus a sector average near 26.36. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing HCM with unrelated industries.